• Certara Introduces New Investigator Awards Program in Australia

    Dec 8, 2017, 08:25 by Michael Croft
    PRINCETON, NJ - Dec 8, 2017 - Certara®, the global leader in model-informed drug development and regulatory science, announced that Leigh Farrell, PhD, Vice President of Corporate Strategy and Business Development, is presenting the inaugural Certara New Investigator Awards in association with the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT)
    Full story

  • CRISPR Therapeutics Announces Planned European Clinical Trial

    Dec 7, 2017, 17:15 by Michael Croft
    Clinical Informatics News Brief | CRISPR Therapeutics today announced the submission of a Clinical Trial Application (CTA) today for CTX001 in β-thalassemia. CTX001 is an investigational CRISPR gene-edited autologous hematopoietic stem cell therapy for patients suffering from β-thalassemia and sickle cell disease. The clinical trial will begin in 2018 in Europe.
    Full story

  • Amazon Cancels Pharmaceutical License Application In Maine

    Dec 6, 2017, 10:30 by Michael Croft
    CNBC |  Amazon appears to have canceled a pharmaceutical wholesaler application in the state of Maine, analysts at RBC Capital Markets pointed out Tuesday, raising further questions about the tech giant's plans to enter the pharmacy space.
    Full story

  • Zika Virus Clinical Trial Says Vaccine Safe Immune Response

    Dec 5, 2017, 14:24 by Michael Croft
    MiamiHerald |  A Zika vaccine developed by scientists at the National Institute of Allergy and Infectious Diseases has cleared the first phase of clinical trials. Findings were published in The Lancet, a medical journal.
    Full story

  • Bioclinica Launches Clinical Adjudication Led by Experienced Medical Specialists and Researchers for Enhanced Safety and Efficacy in Clinical Trials

    Dec 5, 2017, 13:23 by Michael Croft
    DOYLESTOWN, PA, UNITED STATES - Dec 5, 2017 -  Bioclinica®, the world-leading provider of technology-enabled solutions for clinical research, today announces the launch of Bioclinica Clinical Adjudication, a transformational offering in which medical specialists and researchers, backed by advanced technology, lead independent Clinical Event Committee (CEC) review
    Full story

  • Circulation, Lyft Announce Medical Transportation Partnership

    Dec 5, 2017, 09:35 by Michael Croft
    Clinical Informatics News  Circulation today announced a preferred partnership with Lyft, the fastest growing rideshare company in the US. This partnership will expand non-emergency transportation options for Circulation’s clients nationwide, which currently number more than 1,000 healthcare facilities. Starting today, all Circulation users can schedule Lyft rides directly through Circulation’s on-demand patient-centric digital transportation platform.
    Full story

  • Certara Launches Version 17 of its PBPK Simcyp Simulator

    Dec 4, 2017, 09:40 by Michael Croft
    PRINCETON, NJ - Dec 4, 2017 - Certara®, the global leader in model-informed drug development and regulatory science, today announced that it has launched version 17 of its Simcyp® Population-based Simulator
    Full story

  • ERT Acquires iCardiac Technologies

    Dec 4, 2017, 08:20 by Michael Croft
    PHILADELPHIA, PA, UNITED STATES - Dec 4, 2017 -  ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today announced it has acquired iCardiac Technologies, a leading provider of centralized cardiac safety and respiratory solutions that accelerate clinical research
    Full story

  • Bracket, Johnson & Johnson, Bioclinica, And More: News From November 2017

    Dec 4, 2017, 07:00 by Michael Croft

    Clinical Informatics News | November was full of exciting news in the clinical trial and healthcare community, including partnerships, products, and promotions from Bracket, Johnson & Johnson, Bioclinica, and more.

    Full story

  • Deep Learning In The Clinic: Predicting Patient Prognosis

    Dec 1, 2017, 09:55 by Michael Croft
    Clinical Informatics News | In a paper published earlier this month on arXiv, and not yet peer-reviewed, Stanford researchers outlined how machine learning can be made to predict prognosis in a clinical setting.
    Full story

  • Apple Launches Virtual Heart Rhythm Study

    Nov 30, 2017, 12:55 by Michael Croft
    Clinical Informatics News Brief | Apple today launched the Apple Heart Study app, a study using Apple Watch’s heart rate sensor to collect data on irregular heart rhythms and notify users who may be experiencing atrial fibrillation (AFib).
    Full story

  • Alex Azar Addressing Drug Prices Would Be Top Priority At HHS

    Nov 29, 2017, 11:47 by Michael Croft
    STAT |  Alex Azar, President Trump's pick to lead the Health and Human Services Department, didn't mince words when he described his top priority for the agency, telling lawmakers Wednesday that drug prices are too high and must be lowered.
    Full story

  • Tissue Science and Regenerative Medicine

    Nov 29, 2017, 05:56 by Michael Croft
    SYDNEY, AUSTRALIA - Jul 13, 2018 - We are glad to invite you all for 9th International Conference on Tissue Science and Regenerative Medicine
    Full story

  • RxTE Health Appoints Senior Vice President of Clinical Operations

    Nov 28, 2017, 12:48 by Michael Croft
    SILICON VALLEY, CA, UNITED STATES - Nov 28, 2017 - RxTE Health (RxTE), a company specializing in pharmacy cost reduction programs for employers, today announced that it has expanded its executive team with the addition of Sara Linnerooth, PharmD, as Senior Vice President of Clinical Operations
    Full story

  • About 11 Percent Of Drugs In Poor Countries Are Fake, U.N. Says

    Nov 28, 2017, 11:33 by Michael Croft
    STAT |  The medicines are likely responsible for the deaths of tens of thousands of children from diseases like malaria and pneumonia every year.
    Full story

  • WIRB-Copernicus Group Acquires Vigilare International

    Nov 28, 2017, 08:46 by Michael Croft
    PRINCETON, NJ - Nov 28, 2017 - WIRB Copernicus Group® (WCG™), the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced its acquisition of Vigilare International, the top provider of integrated, end-to-end pharmacovigilance and drug safety solutions for the biopharmaceutical and biotech industry
    Full story

  • BioIVT Introduces New Products and Services to Improve Safety, Efficacy and Toxicity Testing for Skin Care Products, Cosmetics and Topical Medications

    Nov 27, 2017, 11:14 by Michael Croft
    WESTBURY, NY - Nov 27, 2017 - BioIVT, a leading provider of biospecimens and related services, today announced that it is launching a new line of products and services to improve safety, efficacy and toxicity testing for skin care products, cosmetics and topical medications
    Full story

  • As Health Care Changes, Insurers, Hospitals, and Drugstores Team Up

    Nov 27, 2017, 11:03 by Michael Croft
    The New York Times |  They seem like odd couples: Aetna, one of the nation's largest health insurers, is in talks to combine with CVS Health, which manages pharmacy benefits. The Cleveland Clinic, a highly regarded health system, joined forces with an insurance start-up, Oscar Health, to offer individuals a health plan in Ohio.
    Full story

  • Tackling The Internet Of Things In Healthcare

    Nov 21, 2017, 11:10 by Michael Croft

    Clinical Informatics News | Cambridge Healthtech Institute’s Inaugural Healthcare Internet of Things event in San Francisco next February aims to bring together constituents and stakeholders to share cases studies and pilot programs that showcase the healthcare industry’s collaborative efforts toward the adoption and implementation of IoT. Here are a few of the talks we have flagged on our agendas.

    Full story

  • Study Uses Real World Evidence To Replicate Pivotal Trial Results

    Nov 21, 2017, 08:31 by Michael Croft
    RAPS |  A study published in JAMA Internal Medicine on Monday was able to replicate the results of a large randomized controlled clinical trial for the blood pressure drug telmisartan using real world evidence gathered from insurance claims data.
    Full story